Skip to main content

Pharmacy Technology

  • P&G unites innovation with value for multipronged campaign

    NEW YORK In response to a national survey, which found that many women often are disappointed with their purchase of household products and desire more product innovation, Procter & Gamble has developed the multipronged “Have You Tried This Yet?” campaign as a way to highlight the manufacturer’s newer, more unique products. As part of the campaign, P&G opened to the public on Oct. 22 an interactive pop-up store in New York to drive awareness and product trials.

    (Click here to view photos of P&G's New York pop-up store.)

  • Genentech's Herceptin receives FDA approval

    SOUTH SAN FRANCISCO, Calif. The Food and Drug Administration has approved a biotech drug for treating cancer of the stomach and esophageal junction.

     

    Genentech, a subsidiary of Swiss drug maker Roche, announced Wednesday the approval of Herceptin (trastuzumab) as a treatment for cancer of the stomach that includes the HER2 gene and has spread to other parts of the body, when combined with chemotherapy. The drug has long since had approval as a treatment for HER2-positive breast cancer.

     

     

  • Centrum invites women to 'take back' time

    MADISON, N.J. Multivitamin maker Centrum is encouraging women to pledge an hour toward an activity that is important to them.

  • In study, insurer shows cost benefits of smarter health decisions by patients

    BLOOMFIELD, Conn. Americans can lower their total medical costs significantly by taking simple steps to prevent or manage disease and by switching to generic drugs whenever possible, new research from health insurance giant Cigna confirmed.

  • Pfizer inks deal with Biocon

    NEW YORK Pfizer has entered the world of biosimilars through a deal with India-based Biocon to distribute versions of insulin and insulin analog products around the world, the companies said Monday.

     

  • SymphonyIRI: Consumers turn to OTCs to curb healthcare costs

    CHICAGO Spurred by a difficult economy, over-the-counter medications increasingly are playing a dual role for consumers looking to minimize healthcare expenditures, the SymphonyIRI Group found in a new research paper titled “Over-the-Counter Medications: State of the Industry 2010” that was released last week.

     

X
This ad will auto-close in 10 seconds